Page last updated: 2024-08-17

prednisone and ipi-145

prednisone has been researched along with ipi-145 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Argnani, L; Casadei, B; Cocito, F; Lolli, G; Pellegrini, C; Zinzani, PL	1

Other Studies

1 other study(ies) available for prednisone and ipi-145

Article	Year
Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report. Tumori, 2021, Volume: 107, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma, T-Cell, Peripheral; Middle Aged; Molecular Targeted Therapy; Prednisone; Purines; Recurrence; Retreatment; T-Lymphocytes, Helper-Inducer; Transplantation, Homologous; Treatment Outcome; Vincristine	2021

Article

Year

Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.

Tumori, 2021, Volume: 107, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Isoquinolines; Lymphoma, T-Cell, Peripheral; Middle Aged; Molecular Targeted Therapy; Prednisone; Purines; Recurrence; Retreatment; T-Lymphocytes, Helper-Inducer; Transplantation, Homologous; Treatment Outcome; Vincristine

2021